nLIGHT Inc
NASDAQ:LASR
nLIGHT Inc
NASDAQ:LASR
Price:
65.37
USD
4.23%
Market Closed
Market Cap:
$3.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
nLIGHT Inc
NASDAQ:LASR
|
US |
|
Fanuc Corp
TSE:6954
|
JP |
|
I
|
Innocan Pharma Corp
CNSX:INNO
|
IL |
Balance Sheet
Balance Sheet Decomposition
nLIGHT Inc
nLIGHT Inc
Balance Sheet Decomposition is not available for
nLIGHT Inc
nLIGHT Inc
Balance Sheet
nLIGHT Inc
nLIGHT Inc
Currency: USD
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
14
|
37
|
150
|
117
|
102
|
147
|
58
|
53
|
66
|
99
|
|
| Cash Equivalents |
14
|
37
|
150
|
117
|
102
|
147
|
58
|
53
|
66
|
99
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
50
|
60
|
35
|
35
|
|
| Total Receivables |
11
|
15
|
28
|
30
|
38
|
51
|
48
|
47
|
49
|
57
|
|
| Accounts Receivables |
10
|
13
|
27
|
30
|
38
|
51
|
48
|
47
|
49
|
57
|
|
| Other Receivables |
1
|
1
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
19
|
30
|
35
|
46
|
55
|
74
|
68
|
52
|
41
|
45
|
|
| Other Current Assets |
3
|
4
|
6
|
5
|
6
|
6
|
7
|
9
|
3
|
7
|
|
| Total Current Assets |
46
|
85
|
219
|
199
|
201
|
277
|
231
|
221
|
194
|
243
|
|
| PP&E Net |
20
|
20
|
23
|
30
|
59
|
75
|
75
|
65
|
58
|
57
|
|
| PP&E Gross |
20
|
20
|
23
|
30
|
59
|
75
|
75
|
65
|
58
|
57
|
|
| Accumulated Depreciation |
43
|
49
|
54
|
59
|
68
|
75
|
83
|
95
|
106
|
100
|
|
| Intangible Assets |
2
|
2
|
3
|
10
|
8
|
7
|
4
|
2
|
1
|
0
|
|
| Goodwill |
1
|
1
|
1
|
10
|
13
|
12
|
12
|
12
|
12
|
12
|
|
| Other Long-Term Assets |
2
|
2
|
4
|
2
|
3
|
3
|
8
|
7
|
5
|
2
|
|
| Other Assets |
1
|
1
|
1
|
10
|
13
|
12
|
12
|
12
|
12
|
12
|
|
| Total Assets |
71
N/A
|
110
+55%
|
250
+127%
|
250
0%
|
284
+13%
|
374
+32%
|
329
-12%
|
307
-7%
|
270
-12%
|
315
+17%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
9
|
13
|
12
|
13
|
21
|
26
|
18
|
12
|
15
|
21
|
|
| Accrued Liabilities |
8
|
12
|
11
|
12
|
17
|
18
|
16
|
16
|
16
|
22
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
20
|
|
| Current Portion of Long-Term Debt |
1
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
2
|
1
|
1
|
3
|
2
|
1
|
5
|
4
|
1
|
|
| Total Current Liabilities |
19
|
29
|
24
|
25
|
41
|
46
|
35
|
33
|
34
|
64
|
|
| Long-Term Debt |
18
|
15
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
4
|
5
|
9
|
8
|
22
|
26
|
24
|
20
|
20
|
24
|
|
| Total Liabilities |
41
N/A
|
49
+18%
|
32
-34%
|
33
+3%
|
64
+91%
|
72
+12%
|
58
-18%
|
52
-10%
|
54
+3%
|
88
+64%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
121
|
119
|
105
|
118
|
138
|
168
|
223
|
264
|
325
|
349
|
|
| Additional Paid In Capital |
153
|
181
|
325
|
337
|
359
|
471
|
496
|
521
|
545
|
578
|
|
| Other Equity |
3
|
1
|
2
|
3
|
0
|
1
|
3
|
2
|
3
|
3
|
|
| Total Equity |
30
N/A
|
61
+106%
|
218
+255%
|
217
-1%
|
220
+2%
|
302
+37%
|
271
-10%
|
254
-6%
|
216
-15%
|
227
+5%
|
|
| Total Liabilities & Equity |
71
N/A
|
110
+55%
|
250
+127%
|
250
0%
|
284
+13%
|
374
+32%
|
329
-12%
|
307
-7%
|
270
-12%
|
315
+17%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
34
|
34
|
37
|
38
|
40
|
44
|
46
|
47
|
49
|
51
|
|
Switch to:
Switch to:
See Also
Discover More
